trial stat - Robuta Search

https://www.statnews.com/2025/11/24/alzheimers-disease-johnson-and-johnson-posdinemab/ J&J’s novel Alzheimer’s drug posdinemab fails in key trial | STAT Nov 24, 2025 - The results could cast shadow over other experimental therapies aimed at the protein tau from companies including Biogen, UCB, and Voyager. key trial j novel drug fails https://www.statnews.com/2026/04/27/veradermics-hair-loss-drug-succeeds-late-stage-trial/ Veradermics’ hair loss drug succeeds in late-stage trial | STAT The company is one of the most advanced players in the hair loss field, which has seen a surge of investor enthusiasm. hair loss drug late stage trial stat succeeds https://www.statnews.com/2026/03/03/prime-medicine-seeks-fda-approval-cgd-disease-gene-editing-treatment/ Prime Medicine seeks FDA treatment approval after two-patient trial | STAT Mar 4, 2026 - Prime Medicine's application will test an FDA that has promised to speed new gene-editing treatments but has recently spurned some. prime medicine trial stat seeks fda treatment https://www.statnews.com/pharmalot/2026/04/14/fda-push-clinical-trial-transparency-novo-nordisk-openai-deal/ Pharmalittle: FDA push for trial transparency, Novo-OpenAI deal | STAT Apr 14, 2026 - AstraZeneca to require hospitals and clinics participating in a U.S. drug discount program to submit claims data for dispensing its drugs pharmalittle fda trial transparency openai deal push novo https://www.statnews.com/2025/12/15/gene-therapy-capsida-biotherapeutics-clinical-trial-death-ramifications/ Gene therapy trial death unnerves promising area of brain research | STAT Dec 16, 2025 - Researchers fear a broad risk for any virus genetically designed to penetrate the blood-brain barrier after no hint of issues prior to Capsida trial death. gene therapy trial brain research death promising area https://www.statnews.com/2026/04/28/fda-clinical-trial-endpoints-real-time-drug-development/ FDA’s scientists can now see clinical trial endpoints in real time | STAT Apr 28, 2026 - FDA Commissioner Marty Makary announces AstraZeneca proof-of-concept real-time clinical trial. clinical trial real time scientists see endpoints https://www.statnews.com/pharmalot/2026/04/17/lilly-weight-loss-pill-results-uk-slashing-clinical-trial-times/ Pharmalittle: Lilly releases obesity pill results, U.K. cuts trial times | STAT Apr 17, 2026 - The FDA may approve testosterone replacement therapy to treat low sex drive in men who do ‌not produce enough of the hormone. obesity pill results u pharmalittle lilly releases https://www.statnews.com/feature/medicine-hunters/part-1/ Before signing up for drug trial, she wants to know: Can I afford it? | STAT Jul 31, 2023 - A cancer patient's question serves as a wake-up call for the drug industry: Will she be able to afford the treatment she’d help usher into the world? drug trial signing wants know afford https://reports.statnews.com/collections/all-reports/products/failed-trial-successful-drug Failed trial, successful drug: How a negative readout can lead to FDA | STAT Reports In this STAT Report author Frank David, M.D., Ph.D., explores the question, how can you tell if there’s still hope a drug will be approved when a pivotal trial... successful drug fda stat failed trial negative https://reports.statnews.com/collections/all-reports/products/clinical-trial-delays Clinical trial delays: what they mean and why you should care | STAT Reports When it comes to clinical trials, time is money. And a delay in a trial can mean a drop in a drug’s net value, lost ground to competitors, or an increased risk... clinical trial care stat delays mean reports